210 related articles for article (PubMed ID: 11785689)
21. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
[TBL] [Abstract][Full Text] [Related]
22. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.
Dubey S; Kalia YN
J Control Release; 2011 Jun; 152(3):356-62. PubMed ID: 21397646
[TBL] [Abstract][Full Text] [Related]
23. Effect of Combination of Low-Frequency Sonophoresis or Electroporation with Iontophoresis on the Mannitol Flux or Electroosmosis through Excised Skin.
Tokumoto S; Higo N; Todo H; Sugibayashi K
Biol Pharm Bull; 2016; 39(7):1206-10. PubMed ID: 27374295
[TBL] [Abstract][Full Text] [Related]
24. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the iontophoretic permselectivity properties of human and pig skin.
Marro D; Guy RH; Delgado-Charro MB
J Control Release; 2001 Jan; 70(1-2):213-7. PubMed ID: 11166421
[TBL] [Abstract][Full Text] [Related]
26. Convective solvent flow across the skin during iontophoresis.
Kim A; Green PG; Rao G; Guy RH
Pharm Res; 1993 Sep; 10(9):1315-20. PubMed ID: 8234169
[TBL] [Abstract][Full Text] [Related]
27. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach.
Denet AR; Ucakar B; Préat V
Pharm Res; 2003 Dec; 20(12):1946-51. PubMed ID: 14725358
[TBL] [Abstract][Full Text] [Related]
28. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
29. The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants.
Gratieri T; Zarhloule R; Dubey S; Kalia YN
Int J Pharm; 2021 Jun; 602():120607. PubMed ID: 33862130
[TBL] [Abstract][Full Text] [Related]
30. Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.
Li SK; Zhang Y; Zhu H; Higuchi WI; White HS
J Pharm Sci; 2005 Apr; 94(4):847-60. PubMed ID: 15736190
[TBL] [Abstract][Full Text] [Related]
31. Modulation of electroosmosis and flux through skin: effect of propylene glycol.
Lee SY; Jeong NY; Oh SY
Arch Pharm Res; 2014 Apr; 37(4):484-93. PubMed ID: 24101411
[TBL] [Abstract][Full Text] [Related]
32. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
Kalaria DR; Patel P; Patravale V; Kalia YN
Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
[TBL] [Abstract][Full Text] [Related]
34. Effect of amino acid sequence on transdermal iontophoretic peptide delivery.
Schuetz YB; Naik A; Guy RH; Kalia YN
Eur J Pharm Sci; 2005 Dec; 26(5):429-37. PubMed ID: 16143501
[TBL] [Abstract][Full Text] [Related]
35. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
36. Enhanced transscleral lontophoretic transport with ion-exchange membrane.
Li SK; Zhu H; Higuchi WI
Pharm Res; 2006 Aug; 23(8):1857-67. PubMed ID: 16841198
[TBL] [Abstract][Full Text] [Related]
37. Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contributions of diffusion, migration, and electroosmosis to transport in hair follicles.
Bath BD; Scott ER; Phipps JB; White HS
J Pharm Sci; 2000 Dec; 89(12):1537-49. PubMed ID: 11042601
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the permselective properties of excised human skin during iontophoresis.
Burnette RR; Ongpipattanakul B
J Pharm Sci; 1987 Oct; 76(10):765-73. PubMed ID: 3123641
[TBL] [Abstract][Full Text] [Related]
39. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Tratta E; Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic studies of the transdermal iontophoretic delivery of 5-OH-DPAT in vitro.
Ackaert OW; Van Smeden J; De Graan J; Dijkstra D; Danhof M; Bouwstra JA
J Pharm Sci; 2010 Jan; 99(1):275-85. PubMed ID: 19718740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
